Navigation Links
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
Date:9/14/2007

7 stock offering and the receipt of $10 million from AstraZeneca upon the signing of the companies' research collaboration and license agreement.

Palatin Technologies' management will discuss the fourth quarter and year end financial results for the fiscal year ended June 30, 2007 and provide an update on corporate developments during a conference call and webcast on September 18, 2007 at 10:00 a.m. ET.

Conference Call and Webcast Access Information

-- Q4-Fiscal Year 2007 Conference Call - Live 9/18/2007 at 10:00 a.m. ET

Domestic Dial-In Number 1-866-454-4203

International Dial-In Number 1-913-312-6693

-- Q4-Fiscal Year 2007 Conference Call - Replay 9/18-9/25/2007

Domestic Dial-In Number 1-888-203-1112

International Dial-In Number 1-719-457-0820

Enter Pass Code I.D. # 4280242

-- Webcast Live and Replay Access http://www.palatin.com

The webcast and replay can be accessed by logging on to the investors

section of Palatin Technologies' website at http://www.palatin.com.

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company focused on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics. The Company's internal research and development capabilities, anchored by its proprietary MIDAS(TM) technology, are fueling product development. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. The Company currently has collaborations with AstraZeneca and the Mallinckrodt division of Covidien. For additional information regarding Palatin, please visit Palatin Technologies' websit
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...VIK,Iceland,November24/PRNewswire-FirstCall/--deCO...provalofallofits,"firstday"motionsbytheU.S.Bankrup...urt").deCODElastweekfiledavoluntarypetitionfor,rel...ththe,BankruptcyCourt. , Theordersissuedbythe...itsbusinessduringtheChapter11proceedings.Inparticu...
(Date:11/24/2009)...EO,Calif.,Nov.24/PRNewswire-FirstCall/--NeurogesX,...edondevelopingandcommercializingnovelpainmanagemen...entandChiefExecutiveOfficer,isscheduledtopresentat...heldDecember1-2,2009atTheNewYorkPalaceHotelinNewYo...iefFinancialOfficer,willbeavailabletorespondtoques...
(Date:11/24/2009)...E,Nov.24/PRNewswire/--BlueMarbleEnergyCorp.announc...Authority(OPDA)wererecentlyawarded$2millionbyWashi...ERB)inaprivate/publicpartnershiptoconstructthestat...unty,WA. ,, "Thisinvestmentwillsignificantlyspe...njobstoLincolnCounty,"saidBlueMarbleEnergyCEOKelly...
(Date:11/24/2009)...yefficacyendpointhasbeenmetforpatientswithadvanced...CITY,Nov.24/PRNewswire-FirstCall/-AEternaZentarisI...opharmaceuticalcompanyfocusedonendocrinetherapyand...ase2studywithitstargetedcytotoxicpeptideconjugate,...ecurrentendometrialcancer.Inapersonalizedhealthcar...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...lif., Oct. 23 WaferGen Biosystems,Inc. (OTC Bulle...the-art,gene expression, genotyping, cell biology ...t Alnoor Shivji, WaferGen,s president and chief,ex...tion at the Seventh,Annual BIO Investor Forum. The...e Palace Hotel in San Francisco, WaferGen,s prese...
...trong Uptake of Soliris(R) in U.S. and Europe, Re...ion of $5.3 Million,for Prior Quarter Shipments, ...e Guidance Downward,and Forecasts GAAP Profit in F...ncology, Transplant, Neurology, Third Quarter 200...b) net product sales of $76.5 million in Q3,2008 c...
... Phenomenal growth in large-scale a...ected to fuel demand for standard as well as highl...atory pumps. Backed by favorable end-use trends, t...2012. , San Jose, CA (PRW...quipment such as pumps is widely used in laborator...
Other Biology Technology:WaferGen to Present at the Seventh Annual BIO Investor Forum 2Alexion Reports Third Quarter 2008 Results 2Alexion Reports Third Quarter 2008 Results 3Alexion Reports Third Quarter 2008 Results 4Alexion Reports Third Quarter 2008 Results 5Alexion Reports Third Quarter 2008 Results 6Alexion Reports Third Quarter 2008 Results 7Alexion Reports Third Quarter 2008 Results 8Alexion Reports Third Quarter 2008 Results 9Alexion Reports Third Quarter 2008 Results 10Alexion Reports Third Quarter 2008 Results 11Alexion Reports Third Quarter 2008 Results 12Alexion Reports Third Quarter 2008 Results 13Alexion Reports Third Quarter 2008 Results 14Laboratory Pumping Systems to Reach $3.1 Billion by 2012, According to New Report by Global Industry Analysts, Inc. 2Laboratory Pumping Systems to Reach $3.1 Billion by 2012, According to New Report by Global Industry Analysts, Inc. 3
(Date:11/25/2009)...t pumps some 250 million liters of blood through t...s of the heart have to be extremely durable. The r...ce chair of the Department of Medicine III at Heid... A. Katus), has discovered a protein that is respo...unit, the sarcomere. In cooperation with other res...
(Date:11/24/2009)...y named 12 new grant recipients for 2009. The awar...rk across a broad spectrum of lupus research. All ...otential to drive scientific discovery to ultimate... systemic lupus. , The 2009 grants go to both ne...ion and include interdisciplinary and highly promi...
(Date:11/24/2009)... class of ring-shaped protein motors has been unco...tional Laboratory (Berkeley Lab) using a state-of-...vanced Light Source (ALS). These protein motors pl...n, and are vital to the survival of all biological...human papillomavirus, which has been linked to cer...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Five Genesis HealthCare Centers To Be Awarded Prestigious National Award 50174 1Five Genesis HealthCare Centers To Be Awarded Prestigious National Award 50174 2Five Genesis HealthCare Centers To Be Awarded Prestigious National Award 50174 3Study shows 1 in 25 deaths worldwide attributable to alcohol 50169 1Study shows 1 in 25 deaths worldwide attributable to alcohol 50169 2In the warming West climate most significant factor in fanning wildfires flames 9017 1In the warming West climate most significant factor in fanning wildfires flames 9017 2
...er,s disease , Two thirds of all patients with dem...ndicate that by 2010 our country will have more th...disease that gradually destroys brain cells, with ...th Alzheimer,s gradually declines. At first, memor...bilities also deteriorate as the disease progresse...
...lease is available in German . , , Plants, alga...s of everything to do with solar energy because th...d sunlight into chemical energy. This is in part b...ransported out of the "light receptor" 1:1 to be u...apanese researchers have now developed a new proce...
...PHIA DHEA is a natural circulating hormone and th...take DHEA as an over-the-counter supplement becaus...g or have anabolic effects since it can be metabol...on of dietary isoflavones is associated with a dec...ium pretense) is one source of isoflavones. Both s...
Other Biology News:New target for medicine to combat Alzheimer's: VIB scientists confirm protein's key role 2Plugging in molecular wires 2New lab evidence suggests preventive effect of herbal supplement in prostate cancer 2
MSC.12 class II safety cabinet (Type A1) - CE Marked (230V / 50Hz) from Thermo Scientific
Kit for BASE20/50 units from Wave Biotech now part of GE Healthcare
...HM-4000 Multidizer is designed with a variety of m...- all in one unit. Shake, rock, roll and rotate mo...rtments allow for hybridization and blotting proce... motion , The upper chamber uses a roller actio...
...A sleek design loaded with class-leading features,...to ensure that your work is safe and consistent ev...w 1400 Series reduces power consumption by as much...ds of dollars over the life of the cabinet. Multi...
Biology Products: